PubMed Health⌕ Search

Biomedical subjects

E Lodetti

Publications and source records attributed to E Lodetti.

7 recordsLinked to original sources

Detection of foot-and-mouth disease virus-infected cattle by assessment of antibody response in oropharyngeal fluids.

The detection of foot-and-mouth disease virus (FMDV)-persistent carriers among convalescent ruminants is of paramount importance in the aftermath of a field outbreak. To this purpose, FMDV-specific antibody should be investigated first, since virus isolation procedures from such carriers are seriously constrained. The complexity of the overall picture may be compounded by possible emergency vaccinations in the affected areas at the beginning of the outbreak. In this case, it is suggested that mucosal rather than serum antibody be investigated. In fact, we showed that FMDV-infected cattle regularly mount an antibody response in oropharyngeal fluids, in contrast to vaccinated cattle. Antibody could be revealed by neutralization assays and/or an immunoglobulin A (IgA)-specific kinetic enzyme-linked immunosorbent assay (ELISA). Cattle vaccinated once seldom showed a mucosal antibody response, which could be only detected by a total immunoglobulin-specific kinetic ELISA. Very few, if any, cattle showed a mucosal IgA response after repeated vaccinations. Our kinetic, IgA-specific ELISA generally allowed an early detection of FMDV-infected cattle; in particular, it proved to be more sensitive than the usual indirect, antigen-trapping ELISA in experiments on saliva samples.

Animals↗

[Ultrastructural aspects of bovine papulous stomatitis virus replicated in cell cultures].

Ultramicroscopic structure of a strain (Mn-73) of BPSV grown on calf kidney primary cultures was investigated. Beside young and mature virions, virus particles with intermediate structural characteristics are described. Size of mature particles on electron microscopic photographs resulted of 270-280 X 140-150 nm, that is a little smaller in comparison with Nagington's et al. (1962) and Büttner's et al. (1964) estimations. Such discrepancy seems to arise from technical artifacts.

Animals↗

Human lymphoblastoid interferon as vaccine adjuvant in cattle.

Human lymphoblastoid interferon from Namalwa cells was purified for clinical use by ethanol fractionation, and used as adjuvant of an inactivated Bovid Herpesvirus 1 vaccine in calves. In agreement with other in vitro and in vivo models, low and high interferon doses were shown to increase and depress the specific antibody response, respectively. The low, effective interferon dose (100 International Units/kg) also reduced the variability of antibody titres after the first vaccine injection. This latter dose had apparently no influence on the regulatory T cell circuits, as opposed to the other doses under study.

Adjuvants, Immunologic↗